Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | BioTech • Medical Devices (& Hospital Services) |
Stages | Expansion, MBO/LBO |
Investing | United States • United Kingdom • Germany • Sweden • Europe • Ireland |
MedCap AB, with headquarters at 47 Queen Anne Street, London, W1G 9JG, United Kingdom, is an active private equity firm specializing in middle-market investments. The firm operates under the brand Inflexion and focuses on various sectors including BioTech, Medical Devices (& Hospital Services), Consumer, Business Services, Healthcare, Industrials, Technology, and Financial Services. Founded in 1999, Inflexion's investment thesis is grounded in a combination of equity, expansion, and management buyout/leveraged buyout (MBO/LBO) strategies. They have established an expertise in equity investments, particularly in facilitating the growth of companies through expansion or transition phases. Inflexion provides flexible funding options through their bespoke funds, designed to cater to the unique needs of the businesses they invest in. Their offerings include a Buyout Fund for majority investments that aim to accelerate growth, Partnership Capital for larger businesses requiring minority capital to maintain control, and an Enterprise Fund for minority or majority stakes in SMEs. On average, companies partnered with Inflexion experience a 21% annual increase in revenues and a doubling of headcount, demonstrating Inflexion's commitment to growth. Inflexion's deep understanding of the challenges faced by entrepreneurs allows them to guide and support the businesses they invest in, rather than take over control. They leverage their comprehensive network and experience to enhance the capabilities of their portfolio companies. The firm boasts a significant track record, having backed over 120 businesses, managing £11 billion in assets, and supporting the employment of 47,371 individuals across their portfolio. Their achievements have been acknowledged through multiple awards in the private equity space, which affirm their excellence in value creation, collaboration, and exit strategies. The Inflexion team values strong partnerships and prioritizes tailoring their investment approach to align the objectives of the individual businesses and their stakeholders. They also emphasize responsible investing by focusing on environmental, social, and governance (ESG) criteria, climate change initiatives, diversity and inclusion, and the Inflexion Foundation, underscoring their commitment to creating sustainable and socially responsible growth.